Associations between plasma PCSK9 levels and postprandial lipemia markers in abdominally obese men with dyslipidemia undergoing lifestyle modification therapy
Associations between plasma PCSK9 levels and postprandial lipemia markers in abdominally obese men with dyslipidemia undergoing lifestyle modification therapy
批准号:
382932
负责人:
Boyer Marjorie
金额:
$0.07万
依托单位国家:
加拿大
项目类别:
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-02-01 至 2019-02-01
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
High LDL cholesterol levels is an important cardiovascular disease (CVD) risk factor. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been identified as a crucial LDL cholesterol level regulator. However, mechanisms regulating PCSK9 remain uncle
期刊论文(0)
专著(0)
科研奖励(0)
会议论文